nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Diphenylpyraline—SLC6A3—Parkinson's disease	0.0109	0.167	CrCbGaD
Mepenzolate—Benzatropine—SLC6A3—Parkinson's disease	0.00834	0.128	CrCbGaD
Mepenzolate—Clemastine—CYP2D6—Parkinson's disease	0.00693	0.107	CrCbGaD
Mepenzolate—Trospium—CYP2D6—Parkinson's disease	0.0068	0.105	CrCbGaD
Mepenzolate—Darifenacin—CYP2D6—Parkinson's disease	0.00494	0.076	CrCbGaD
Mepenzolate—Fexofenadine—CYP2D6—Parkinson's disease	0.0048	0.074	CrCbGaD
Mepenzolate—Benzatropine—CYP2D6—Parkinson's disease	0.00438	0.0675	CrCbGaD
Mepenzolate—Fexofenadine—ABCB1—Parkinson's disease	0.00343	0.0528	CrCbGaD
Mepenzolate—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.00321	0.0494	CrCbGaD
Mepenzolate—Loperamide—CYP2D6—Parkinson's disease	0.00306	0.0471	CrCbGaD
Mepenzolate—Fentanyl—ABCB1—Parkinson's disease	0.00227	0.0349	CrCbGaD
Mepenzolate—Loperamide—ABCB1—Parkinson's disease	0.00218	0.0336	CrCbGaD
Mepenzolate—Methadone—CYP2D6—Parkinson's disease	0.00218	0.0335	CrCbGaD
Mepenzolate—Methadone—ABCB1—Parkinson's disease	0.00155	0.0239	CrCbGaD
Mepenzolate—CHRM3—GPCR ligand binding—DRD1—Parkinson's disease	0.00131	0.0014	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.0013	0.00139	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—GRK5—Parkinson's disease	0.0013	0.00139	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.00129	0.00138	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00129	0.00138	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.00129	0.00138	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—GRM4—Parkinson's disease	0.00128	0.00137	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—TALDO1—Parkinson's disease	0.00128	0.00137	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—OMD—Parkinson's disease	0.00128	0.00137	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00127	0.00136	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00127	0.00136	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—DRD3—Parkinson's disease	0.00126	0.00135	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.00125	0.00134	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00123	0.00132	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00123	0.00131	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00123	0.00131	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—VPS35—Parkinson's disease	0.00122	0.00131	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00122	0.00131	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PENK—Parkinson's disease	0.00122	0.0013	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00122	0.0013	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—NDUFB11—Parkinson's disease	0.00121	0.0013	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	0.00121	0.0013	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00121	0.00129	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	0.00121	0.00129	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.0012	0.00129	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00119	0.00127	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00117	0.00125	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—GRM4—Parkinson's disease	0.00117	0.00125	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GCH1—Parkinson's disease	0.00116	0.00124	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	0.00115	0.00123	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00115	0.00123	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00115	0.00123	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—HTR7—Parkinson's disease	0.00114	0.00122	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—DRD2—Parkinson's disease	0.00114	0.00122	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	0.00113	0.00121	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	0.00113	0.00121	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00112	0.00119	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PDYN—Parkinson's disease	0.00111	0.00119	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	0.00111	0.00119	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PENK—Parkinson's disease	0.00111	0.00118	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	0.0011	0.00118	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	0.00109	0.00117	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00108	0.00115	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00107	0.00115	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00105	0.00113	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00105	0.00112	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00104	0.00111	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00104	0.00111	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—GRM5—Parkinson's disease	0.00104	0.00111	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GBA—Parkinson's disease	0.00103	0.0011	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—FBP1—Parkinson's disease	0.00103	0.0011	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—DBH—Parkinson's disease	0.00103	0.0011	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	0.00102	0.0011	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.00102	0.00109	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.00102	0.00109	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.00101	0.00108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GPR37—Parkinson's disease	0.00101	0.00108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—DGKQ—Parkinson's disease	0.00101	0.00108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PDYN—Parkinson's disease	0.00101	0.00108	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	0.001	0.00107	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	0.001	0.00107	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	0.001	0.00107	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.000943	0.00101	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—GRM5—Parkinson's disease	0.00094	0.00101	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	0.000931	0.000995	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00093	0.000994	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000927	0.000991	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.000918	0.000982	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000918	0.000982	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—EDN1—Parkinson's disease	0.000915	0.000979	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	0.000906	0.000969	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000883	0.000944	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00088	0.000941	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000872	0.000932	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000817	0.000874	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000813	0.000869	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	0.00081	0.000866	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000803	0.000859	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.000802	0.000858	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000802	0.000857	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	0.000801	0.000856	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000799	0.000855	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000793	0.000848	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000791	0.000846	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000781	0.000836	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.00077	0.000824	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.000768	0.000821	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000766	0.000819	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000764	0.000817	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.000761	0.000813	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—DDC—Parkinson's disease	0.000756	0.000809	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000756	0.000809	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000754	0.000807	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.000752	0.000804	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000745	0.000796	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00074	0.000791	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000737	0.000789	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.00073	0.000781	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000717	0.000766	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000714	0.000764	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.000714	0.000764	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000707	0.000756	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000696	0.000744	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.000693	0.000742	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000691	0.000739	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.000689	0.000737	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000687	0.000734	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000685	0.000733	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.000683	0.00073	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.000682	0.00073	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000676	0.000723	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000672	0.000719	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.00067	0.000716	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000669	0.000716	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000667	0.000713	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000663	0.000709	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00066	0.000706	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000655	0.000701	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000655	0.000701	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.000653	0.000698	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.000653	0.000698	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000651	0.000696	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.000649	0.000694	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000648	0.000693	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000648	0.000693	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000647	0.000692	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000647	0.000692	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000646	0.000691	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000646	0.000691	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.000643	0.000688	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.000642	0.000687	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.00064	0.000684	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.00064	0.000684	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000637	0.000681	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000631	0.000674	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000608	0.00065	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000606	0.000648	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.0006	0.000641	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000599	0.000641	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000597	0.000639	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000591	0.000633	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000588	0.000629	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000588	0.000629	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.000587	0.000627	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.000587	0.000627	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000581	0.000621	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000581	0.000621	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000563	0.000602	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000562	0.000601	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000557	0.000596	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000556	0.000595	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.000555	0.000594	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.00055	0.000588	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000522	0.000558	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000519	0.000555	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000517	0.000553	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000512	0.000548	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000494	0.000529	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000493	0.000527	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000488	0.000522	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.000487	0.000521	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.000482	0.000516	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000474	0.000507	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000473	0.000506	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000472	0.000505	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000471	0.000504	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.00047	0.000502	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000468	0.0005	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.000465	0.000497	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000464	0.000497	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000454	0.000485	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000452	0.000484	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000448	0.000479	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000437	0.000467	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.000436	0.000466	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000433	0.000463	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—INSR—Parkinson's disease	0.000431	0.000461	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000428	0.000458	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—TH—Parkinson's disease	0.000422	0.000451	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000413	0.000442	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000412	0.000441	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.000412	0.00044	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000411	0.000439	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000411	0.000439	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.00041	0.000438	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FGB—Parkinson's disease	0.000408	0.000436	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000407	0.000435	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	0.000406	0.000434	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000405	0.000433	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000405	0.000433	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000403	0.000431	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	0.0004	0.000427	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000397	0.000424	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.000396	0.000423	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	0.000392	0.000419	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000384	0.000411	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000383	0.00041	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	0.000379	0.000406	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000359	0.000384	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—COMT—Parkinson's disease	0.000359	0.000383	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000358	0.000383	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.000357	0.000382	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MAOA—Parkinson's disease	0.000356	0.000381	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000354	0.000379	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000352	0.000376	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000348	0.000372	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000348	0.000372	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000347	0.000371	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000347	0.000371	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	0.000343	0.000367	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	0.000343	0.000367	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000338	0.000361	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000328	0.000351	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GPX1—Parkinson's disease	0.000314	0.000336	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000291	0.000312	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.00029	0.000311	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.00029	0.00031	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	0.000288	0.000308	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000282	0.000301	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.000281	0.0003	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000278	0.000298	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	0.000278	0.000297	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000277	0.000297	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	0.000275	0.000294	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOE—Parkinson's disease	0.00027	0.000289	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000256	0.000274	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.000255	0.000273	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NGF—Parkinson's disease	0.000252	0.00027	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000243	0.00026	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000243	0.00026	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	0.00024	0.000257	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—INS—Parkinson's disease	0.000231	0.000247	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000226	0.000242	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOE—Parkinson's disease	0.000226	0.000241	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOE—Parkinson's disease	0.000223	0.000239	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.000193	0.000207	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—INS—Parkinson's disease	0.000193	0.000206	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—INS—Parkinson's disease	0.000191	0.000204	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000144	0.000154	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	0.000144	0.000153	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000143	0.000153	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	0.000143	0.000152	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	0.000142	0.000152	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	0.000141	0.000151	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000132	0.000142	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	0.000132	0.000141	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	0.000131	0.00014	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6—Parkinson's disease	8.45e-05	9.04e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6—Parkinson's disease	8.42e-05	9.01e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6—Parkinson's disease	8.34e-05	8.92e-05	CbGpPWpGaD
